Serum platelet-activating factor acetylhydrolase (PAF-AH) activity in patients with hyperbilirubinemic hepatobiliary disease

Hepatology Research

Volumn 26, Issue 1, 2003, Pages 23-27

  Kamisako, Toshinori ^a   Takeuchi, Keisuke ^b   Ito, Tadashi ^c   Tamaki, Shigenori ^b   Kosaka, Tetsuya ^d   Adachi, Yukihiko ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Osaka Railway Hospital   (Japan)

^d Azwell Inc   (Japan)

Author keywords

Acute hepatitis; Cholesterol; Interleukin 6; LDL cholesterol; Liver cirrhosis; Obstructive cholestasis; Tumor necrosis factor

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BILIRUBIN; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; BILE FLOW; BILIRUBIN BLOOD LEVEL; CATALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEPATOBILIARY DISEASE; HUMAN; HYPERBILIRUBINEMIA; LIVER CIRRHOSIS; MALE; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN HYDROLYSIS; REGULATORY MECHANISM; REMISSION; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0042592939     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(03)00006-8     Document Type: Article

References (12)

1. Imaizumi T, Stafforini DM, Yamada Y, McIntyre TM, Prescott SM, Zimmerman GA. Platelet-activating factor: a mediator for clinicians. J Int Med 1995;238:5-20.
2. Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J Biol Chem 1989;264:5331-4.
3. Tjoelker LW, Stafforini DM. Platelet-activating factor acetylhydrolases in health and disease. Biochim Biophys Acta 2000;1488:102-23.
4. Meade CJ, Metcalfe S, Svvennsen R, Jamieson N, Watson C, Calne RY, Kleber G, Neild G. Serum PAF acetylhydrolase and chronic cholestasis. Lancet 1991;338:1016-7.
5. Kosaka T, Yamaguchi M, Soda Y, Kishimoto T, Tago A, Toyosato M, Mizuno K. Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity. Clin Chim Acta 2000;296:151-61.
6. Meade CJ, Birke F, Metcalfe S, Watson C, Jamieson N, Neild G. Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation. J Lipid Mediat Cell Signal 1994;9:205-15.
7. Caramelo C, Fernandez-Gallardo S, Santos JC, Inarrea P, Sanchez-Crespo M, Lopez-Novoa JM, Hernando L. Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver. Eur J Clin Invest 1987;17:7-11.
8. Stafforini DM, Elstad MR, McIntyre TM, Zimmerman GA, Prescott SM. Human macrophages secrete platelet-activating factor acetylhydrolase. J Biol Chem 1990;265:9682-7.
9. Howard KM, Miller JE, Miwa M, Olson MS. Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem 1997;272:27543-8.
10. Memon RA, Fuller J, Moser AH, Feingold KR, Grunfeld C. In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. Am J Physiol 1999;277:R94-103.
11. Guerra R, Zhao B, Mooser V, Stafforini D, Johnston JM, Cohen JC. Determinants of plasma platelet-activating factor acetylhydrolase: heritability and relationship to plasma lipoproteins. J Lipid Res 1997;38:2281-8.
12. Svetlov SI, Sturm E, Olson MS, Crawford JM. Hepatic regulation of platelet-activating factor acetylhydrolase and lecithin:cholesterol acyltransferase biliary and plasma output in rats exposed to bacterial lipopolysaccharide. Hepatology 1999;30:128-36.